Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Active
Last updated: January 7, 2026
Eucontra

68mg Resorbable Implant

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Subdermal
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Hera Health Solutions
Active
Last updated: January 7, 2026
ENG Pellets

Casea S

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Subdermal
  • Intended Duration: Long-Acting
  • Development Stage: Phase I
  • Developer(s)/Researcher(s): GeSea Biosciences, FHI 360, Daré Biosciences, Theramex
Active
Last updated: January 7, 2026
EFdA-p + Progestin Intravaginal Film
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Vaginal Gel
  • Intended Duration: Short-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Magee-Women's Research Institute, University of Pittsburgh
Active
Last updated: January 7, 2026
Drug-Eluting Nanofibers

Electrospun Fiber Mesh Contraceptive

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal - Other
  • Intended Duration: Short-Acting
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): University of Washington, HLL Lifecare
Inactive
Last updated: January 7, 2026
Dihydropyridine Calcium Channel Antagonists

Nifedipine, Amlodipine

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Not Yet Determined
  • Intended Duration: Not Yet Determined
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Rawalpindi Medical University, University of Basra, Babcock University
Active
Last updated: January 5, 2026
Dare-LARC1

Microchip Implant

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Subdermal
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Dare BioScience Inc.
Active
Last updated: January 5, 2026
Dapivirine + Levonorgestrel Intravaginal Ring
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Vaginal Ring
  • Intended Duration: Short-Acting
  • Development Stage: Phase I
  • Developer(s)/Researcher(s): International Partnership for Microbicides/Population Council, Microbicide Trials Network and the Contraceptive Clinical Trials Network, NIH
Active
Last updated: January 5, 2026
Dapivirine + Levonorgestrel Extended-Release Monthly Film

DPV + LNG Monthly Film

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Vaginal Gel
  • Intended Duration: Short-Acting
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Magee-Women's Research Institute, University of Pittsburgh
Active
Last updated: January 5, 2026
Copper, Zinc Acetate, and Lactide Intravaginal Ring

CZL-IVR

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal Ring
  • Intended Duration: Short-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Population Council, Queen's University Belfast, Weill Cornell Medical College